Akebia Therapeutics
AKBA
AKBA
153 hedge funds and large institutions have $532M invested in Akebia Therapeutics in 2019 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 50 increasing their positions, 46 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
9% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 46
0.88% less ownership
Funds ownership: 71.7% → 70.83% (-0.88%)
Holders
153
Holding in Top 10
–
Calls
$4.36M
Puts
$1.46M
Top Buyers
| 1 | +$5.99M | |
| 2 | +$3.93M | |
| 3 | +$3.7M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.14M |
Top Sellers
| 1 | -$31M | |
| 2 | -$4.81M | |
| 3 | -$2.02M | |
| 4 |
Citigroup
New York
|
-$1.62M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.29M |